PMID- 27852742 OWN - NLM STAT- MEDLINE DCOM- 20170808 LR - 20181113 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 198 IP - 1 DP - 2017 Jan 1 TI - Soluble TNF Regulates TACE via AP-2alpha Transcription Factor in Mouse Dendritic Cells. PG - 417-427 AB - Dendritic cells (DCs), the essential immunoregulatory and APCs, are major producers of the central mediator of inflammation, soluble TNF-alpha (sTNF). sTNF is generated by TNF-alpha converting enzyme (TACE) proteolytic release of the transmembrane TNF (tmTNF) ectodomain. The mechanisms of TACE and sTNF regulation in DCs remain elusive. This study newly defines that sTNF regulates TACE in mouse DCs by engaging the AP-2alpha transcription factor. We found that the expression of AP-2alpha was higher, whereas the expression and activity of TACE were lower, in wild-type DCs (wtDCs) than in TNF knockout (TNFko) DCs. Exogenous sTNF rapidly and simultaneously induced increases of AP-2alpha expression and decreases of TACE expression and activity in wtDCs and TNFko DCs, indicating that AP-2alpha and TACE are inversely dependent on sTNF and are functionally associated. To define this functional association, we identified an AP-2alpha binding site in TACE promoter and demonstrated, using EMSAs and chromatin immunoprecipitation assays, that AP-2alpha could bind to TACE promoter in a TNF-dependent manner. Additionally, sTNF simultaneously enhanced AP-2alpha expression and decreased TACE promoter luciferase activity in DCs. Similarly, transfection of AP-2alpha cDNA decreased TACE promoter luciferase activity, TACE expression, and TACE enzymatic activity in wtDCs or TNFko DCs. In contrast, transfection of AP-2alpha small interfering RNA increased TACE promoter luciferase activity, TACE expression, and TACE enzymatic activity in wtDCs. These results show that TACE is a target of, and is downregulated by, sTNF-induced AP-2alpha transcription factor in DCs. CI - Copyright (c) 2016 by The American Association of Immunologists, Inc. FAU - Ge, Lisheng AU - Ge L AD - Department of Pathology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232. FAU - Vujanovic, Nikola L AU - Vujanovic NL AD - Department of Pathology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232; vujanovicnl@upmc.edu. AD - Department of Immunology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232; and. AD - VA Pittsburgh Healthcare System, Pittsburgh, PA 15261. LA - eng GR - R01 DE014775/DE/NIDCR NIH HHS/United States GR - R01 DE017150/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20161116 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Transcription Factor AP-2) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.24.86 (ADAM17 Protein) RN - EC 3.4.24.86 (Adam17 protein, mouse) SB - IM MH - ADAM17 Protein/immunology/*metabolism MH - Animals MH - Chromatin Immunoprecipitation MH - Dendritic Cells/immunology/*metabolism MH - Electrophoretic Mobility Shift Assay MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Gene Expression Regulation/immunology MH - Immunoblotting MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Transcription Factor AP-2/immunology/*metabolism MH - Tumor Necrosis Factor-alpha/immunology/*metabolism PMC - PMC5173404 MID - NIHMS826470 EDAT- 2016/11/18 06:00 MHDA- 2017/08/09 06:00 PMCR- 2018/01/01 CRDT- 2016/11/18 06:00 PHST- 2016/03/24 00:00 [received] PHST- 2016/10/25 00:00 [accepted] PHST- 2016/11/18 06:00 [pubmed] PHST- 2017/08/09 06:00 [medline] PHST- 2016/11/18 06:00 [entrez] PHST- 2018/01/01 00:00 [pmc-release] AID - jimmunol.1600524 [pii] AID - 10.4049/jimmunol.1600524 [doi] PST - ppublish SO - J Immunol. 2017 Jan 1;198(1):417-427. doi: 10.4049/jimmunol.1600524. Epub 2016 Nov 16.